These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 21287692)
1. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Fatima N; Cohen C; Lawson D; Siddiqui MT Cancer Cytopathol; 2011 Apr; 119(2):127-33. PubMed ID: 21287692 [TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid. Liu L; Cohen C; Siddiqui MT Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220 [TBL] [Abstract][Full Text] [Related]
3. Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma. Johnson H; Cohen C; Fatima N; Duncan D; Siddiqui MT Acta Cytol; 2012; 56(6):596-602. PubMed ID: 23207437 [TBL] [Abstract][Full Text] [Related]
4. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Stoll LM; Johnson MW; Gabrielson E; Askin F; Clark DP; Li QK Cancer Cytopathol; 2010 Dec; 118(6):441-9. PubMed ID: 20830690 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962 [TBL] [Abstract][Full Text] [Related]
6. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Kim MJ; Shin HC; Shin KC; Ro JY Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737 [TBL] [Abstract][Full Text] [Related]
7. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482 [TBL] [Abstract][Full Text] [Related]
8. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases. Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515 [TBL] [Abstract][Full Text] [Related]
9. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Mukhopadhyay S; Katzenstein AL Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283 [TBL] [Abstract][Full Text] [Related]
10. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas. Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392 [TBL] [Abstract][Full Text] [Related]
11. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion. Kim JH; Kim YS; Choi YD; Lee JS; Park CS Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings. Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589 [TBL] [Abstract][Full Text] [Related]
13. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132 [TBL] [Abstract][Full Text] [Related]
14. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations. Liu J; Farhood A Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255 [TBL] [Abstract][Full Text] [Related]
15. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Bishop JA; Sharma R; Illei PB Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516 [TBL] [Abstract][Full Text] [Related]
16. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963 [TBL] [Abstract][Full Text] [Related]
17. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung. Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761 [TBL] [Abstract][Full Text] [Related]
18. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169 [TBL] [Abstract][Full Text] [Related]
19. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374 [TBL] [Abstract][Full Text] [Related]
20. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]